Skip to content

Study of the neuroimaging characteristics of insomnia in high-altitude environments based on fNIRS technology.

Investigation into Central Response Characteristics of Ear Acupoint Pressing Needle Intervention for Insomnia in High-Altitude Environments Based on fNIRS Technology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2026000342
Enrollment
Unknown
Registered
2026-02-09
Start date
2026-02-14
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Interventions

Insomnia group under high-altitude environment:None
The non-insomnia group under high-altitude environment:None

Sponsors

General Hospital of Western Theater Command of the People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for insomnia subjects: (1) Residing in an area with an altitude =2500 meters; (2) Age between 18 and 60 years old; (3) Possess basic reading and writing skills and can independently complete the questionnaire; (4) Voluntarily participate in this study and sign the informed consent form; (5) Meet the diagnostic criteria for insomnia; (6) Right-handed. Inclusion criteria for healthy subjects: (1) Residing in an area with an altitude =2500 meters; (2) Age between 18 and 60 years old; (3) Possess basic reading and writing skills and can independently complete the questionnaire; (4) Voluntarily participate in this study and sign the informed consent form; (5) Do not meet the diagnostic criteria for insomnia; (6) Right-handed.

Exclusion criteria

Exclusion criteria: Subjects meeting any of the following criteria will be excluded: (1) Subjects diagnosed with insomnia in plain areas; (2) Patients with severe physical diseases or mental disorders; (3) Patients with severe anxiety or depression (SDS =73 points, SAS =70 points); (4) Subjects who have regularly taken sedative-hypnotic or other sleep aids, or antidepressant and anxiolytic medications within the past month; (5) Subjects currently participating in other clinical trials targeting insomnia; (6) Other subjects deemed unsuitable for participation in the clinical trial by the investigators for any reason.

Design outcomes

Primary

MeasureTime frame
Functional Near-Infrared Spectroscopy (fNIRS) Imaging Detection;

Countries

China

Contacts

Public ContactWang Wenchun

General Hospital of Western Theater Command of the People's Liberation Army

wwc1977biology@163.com18908069418

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Mar 14, 2026